Skip to Main Content

Paper Details

Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial.
Am J Cardiol
2
2023
Aspirin, CDR, NACEs, Patients, Ticagrelor, all-cause, aspirin, myocardial infarction, patients, stroke, ticagrelor
Author NameAffiliation
Usman BaberThe University of Oklahoma Health Sciences Center
Samantha SartoriThe Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai
David J CohenCardiovascular Research Foundation, New York St. Francis Hospital
Roxana MehranThe Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai
  • 1 - 4

Datasets

Release 1.2